Search research articles
Contact Us
Filters
Showing results (11-20 of 160) with videos related to
Page
of 16
Sort By:
Annals of the Rheumatic Diseases
|
May 22, 2020
EULAR PsA management recommendations 2019: can the recommendations be improved?
Roy M Fleischmann
The Journal of Rheumatology. Supplement
|
November 1, 1992
Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis
R M Fleischmann
Arthritis and Rheumatism
|
October 31, 2009
Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis
R M Fleischmann
Rheumatic Diseases Clinics of North America
|
April 7, 2007
Comparison of the efficacy of biologic therapy for rheumatoid arthritis: can the clinical trials be accurately compared?
Roy M Fleischmann
Zeitschrift Fur Gerontologie Und Geriatrie
|
March 1, 1997
[Progress in psychogerontology at German universities]
U M Fleischmann
Rheumatology (Oxford, England)
|
June 21, 2003
Addressing the safety of anakinra in patients with rheumatoid arthritis
R M Fleischmann
Clinical Therapeutics
|
October 6, 1999
Early diagnosis and treatment of rheumatoid arthritis for improved outcomes: focus on etanercept, a new biologic response modifier
R M Fleischmann
The Journal of Rheumatology. Supplement
|
September 19, 2002
Examining the efficacy of biologic therapy: are there real differences?
Roy M Fleischmann
Die Rehabilitation
|
February 1, 1985
[Memory related training in advanced age]
U M Fleischmann
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca
|
June 1, 1977
[The use of total hip joint replacement in states following sliding osteotomy according to Mc Murray and angulation osteotomy after Milch (author's transl)]
M Fleischmann, J Knĕzek
Page
of 16
Search research articles
Search
Showing results (11-20 of 160) with videos related to
Sort By:
Page
of 16
Annals of the Rheumatic Diseases
|
May 22, 2020
EULAR PsA management recommendations 2019: can the recommendations be improved?
Roy M Fleischmann
The Journal of Rheumatology. Supplement
|
November 1, 1992
Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis
R M Fleischmann
Arthritis and Rheumatism
|
October 31, 2009
Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis
R M Fleischmann
Rheumatic Diseases Clinics of North America
|
April 7, 2007
Comparison of the efficacy of biologic therapy for rheumatoid arthritis: can the clinical trials be accurately compared?
Roy M Fleischmann
Zeitschrift Fur Gerontologie Und Geriatrie
|
March 1, 1997
[Progress in psychogerontology at German universities]
U M Fleischmann
Rheumatology (Oxford, England)
|
June 21, 2003
Addressing the safety of anakinra in patients with rheumatoid arthritis
R M Fleischmann
Clinical Therapeutics
|
October 6, 1999
Early diagnosis and treatment of rheumatoid arthritis for improved outcomes: focus on etanercept, a new biologic response modifier
R M Fleischmann
The Journal of Rheumatology. Supplement
|
September 19, 2002
Examining the efficacy of biologic therapy: are there real differences?
Roy M Fleischmann
Die Rehabilitation
|
February 1, 1985
[Memory related training in advanced age]
U M Fleischmann
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca
|
June 1, 1977
[The use of total hip joint replacement in states following sliding osteotomy according to Mc Murray and angulation osteotomy after Milch (author's transl)]
M Fleischmann, J Knĕzek
Page
of 16